Mercury Biopharmaceutical (ROCO:6932) Other Long Term Assets : NT$11.37 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Mercury Biopharmaceutical Other Long Term Assets?

Mercury Biopharmaceutical's other long-term assets for the quarter that ended in Dec. 2024 was NT$11.37 Mil.

Mercury Biopharmaceutical's quarterly other long-term assets declined from Dec. 2023 (NT$15.50 Mil) to Jun. 2024 (NT$11.55 Mil) but then stayed the same from Jun. 2024 (NT$11.55 Mil) to Dec. 2024 (NT$11.37 Mil).

Mercury Biopharmaceutical's annual other long-term assets increased from Dec. 2022 (NT$8.55 Mil) to Dec. 2023 (NT$15.50 Mil) but then declined from Dec. 2023 (NT$15.50 Mil) to Dec. 2024 (NT$11.37 Mil).

Mercury Biopharmaceutical Other Long Term Assets Historical Data

The historical data trend for Mercury Biopharmaceutical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Biopharmaceutical Other Long Term Assets Chart

Mercury Biopharmaceutical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

0.51

8.55

15.50

11.37

Mercury Biopharmaceutical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial					8.55	14.17	15.50	11.55	11.37

Mercury Biopharmaceutical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Mercury Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Biopharmaceutical Corp (ROCO:6932) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 653-1, Bannan Road, 15th Floor, Zhonghe District, New Taipei City, TWN

Website

https://www.merdury.com.tw

Mercury Biopharmaceutical Corp focuses on the development of drugs for unmet medical needs. It offers a development platform focusing on rapid release and free adjustable doses. Its 3D powder bonding method (binder jetting) combines powder and special molding adhesive and stacks them in layers.

Mercury Biopharmaceutical Headlines

No Headlines